Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (161-170 of 297) with videos related to

Pageof 30
Sort By:
Journal of Cancer Research and Clinical Oncology|March 20, 2020
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer centerAnja Welt, Simon Bogner, Marina Arendt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Cancer Research|March 17, 2021
GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal CancerAlexandra Adamczyk, Eva Pastille, Jan Kehrmann, et al.
Clinical Lung Cancer|September 13, 2018
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaFiliz Oezkan, Thomas Herold, Kaid Darwiche, et al.
Cancer Research|June 8, 2014
Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancerEva Pastille, Katrin Bardini, Diana Fleissner, et al.
Computers in Biology and Medicine|June 24, 2025
From BERT to generative AI - Comparing encoder-only vs. large language models in a cohort of lung cancer patients for named entity recognition in unstructured medical reportsKamyar Arzideh, Henning Schäfer, Héctor Allende-Cid, et al.
Immunotherapy|July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factorsMaja Guberina, Nika Guberina, Christoph Pöttgen, et al.
Cells|February 25, 2025
BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOKPalaniappan Ramesh, Amal R Al Kadi, Gaurav M Borse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2024
PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitorsTanja Abu Sabbah, Sarah Theurer, Hideo Andreas Baba, et al.
Pageof 30

Showing results (161-170 of 297) with videos related to

Sort By:
Pageof 30
Journal of Cancer Research and Clinical Oncology|March 20, 2020
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer centerAnja Welt, Simon Bogner, Marina Arendt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 PatientsJustin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, et al.
Cancer Research|March 17, 2021
GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal CancerAlexandra Adamczyk, Eva Pastille, Jan Kehrmann, et al.
Clinical Lung Cancer|September 13, 2018
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung AdenocarcinomaFiliz Oezkan, Thomas Herold, Kaid Darwiche, et al.
Cancer Research|June 8, 2014
Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancerEva Pastille, Katrin Bardini, Diana Fleissner, et al.
Computers in Biology and Medicine|June 24, 2025
From BERT to generative AI - Comparing encoder-only vs. large language models in a cohort of lung cancer patients for named entity recognition in unstructured medical reportsKamyar Arzideh, Henning Schäfer, Héctor Allende-Cid, et al.
Immunotherapy|July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factorsMaja Guberina, Nika Guberina, Christoph Pöttgen, et al.
Cells|February 25, 2025
BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOKPalaniappan Ramesh, Amal R Al Kadi, Gaurav M Borse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2024
PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitorsTanja Abu Sabbah, Sarah Theurer, Hideo Andreas Baba, et al.
Pageof 30